Structure 10-DAB semisynthetic paclitaxel CAS 33069-62-4

Iden­ti­fi­ca­tion

CAS Number

33069-62-4

Name

10-DAB semi­syn­thet­ic paclitaxel

Syn­onyms

(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetyloxy)-1,9-dihydroxy-15-({(2R,3S)-2-hydroxy-3-phenyl-3-[(phenylcarbonyl)amino]propanoyl}oxy)-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl ben­zoate
(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-Bis(acetyloxy)-1,9-dihydroxy-15-({(2R,3S)-2-hydroxy-3-phenyl-3-[(phenylcarbonyl)amino]propanoyl}oxy)-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-ylbenzolcarboxylat
(2a,5b,7b,10b,13a)-4,10-bis(acetyloxy)-13-{[(2R,3S)-3-(benzoylamino)-2-hydroxy-3-phenylpropanoyl]oxy}-1,7-dihydroxy-9-oxo-5,20-epoxytax-11-en-2-yl ben­zoate
(2α,5β,7β,10β,13α)-4,10-bis(acetyloxy)-1,7-dihydroxy-13-({(2R,3S)-2-hydroxy-3-phenyl-3-[(phenylcarbonyl)amino]propanoyl}oxy)-9-oxo-5,20-epoxytax-11-en-2-yl ben­zoate
(2α,5β,7β,10β,13α)-4,10-Diacetoxy-13-{[(2R,3S)-3-(benzoylamino)-2-hydroxy-3-phenylpropanoyl]oxy}-1,7-dihydroxy-9-oxo-5,20-epoxytax-11-en-2-yl ben­zoate [ACD/IUPAC Name]
(2α,5β,7β,10β,13α)-4,10-Diacetoxy-13-{[(2R,3S)-3-(benzoylamino)-2-hydroxy-3-phenylpropanoyl]oxy}-1,7-dihydroxy-9-oxo-5,20-epoxytax-11-en-2-yl-benzoat [Ger­man] [ACD/IUPAC Name]
33069-62-4 [RN]
5b,20-Epoxy-1,2a,4,7b,10b,13a-hexahydroxytax-11-en-9-one 4,10-Diacetate 2-Ben­­zoate 13-Ester with (2R,3S)-N-Ben­zoyl-3-phenylisoser­ine
Anzatax [Trade name]
ben­zene­propanoic acid, b-(benzoylamino)-a-hydroxy-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, (aR,bS)-
Ben­zene­propanoic acid, β-(benzoylamino)-α-hydroxy-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13
,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, (αR,βS)- [ACD/​Index Name]
Ben­zene­propanoic acid, β-(benzoylamino)-α-hydroxy-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, (αR,βS)-
Ben­zoate de (2α,5β,7β,10β,13α)-4,10-diacétoxy-13-{[(2R,3S)-3-(benzoylamino)-2-hydroxy-3-phénylpropanoyl]oxy}-1,7-dihydroxy-9-oxo-5,20-époxytax-11-én-2-yle [French] [ACD/IUPAC Name]
BMS 181339-01
Ebe­tax­el [Trade name]
LipoPac [Trade name]
Onx­ol [Trade name]
pacli­tax­el [Span­ish] [INN]
pacli­tax­el [French] [INN]
Pacli­tax­el [BAN] [INN] [USAN] [Wiki]
pacli­tax­elum [Latin] [INN]
Pax­ceed [Trade name]
Pax­ene
Pecli­tax­el
Plaxi­cel [Trade name]
Tax­Al­bin
Tax­ol [Trade name]
Tax­ol A
UNII-P88X­T4IS4D
Yew­tax­an
паклитаксел [Russ­ian] [INN]
باكليتاكسال [Ara­bic] [INN]
紫杉醇 [Chi­nese] [INN]
cyclopax
(1R,5S,6S,7R,10S,14S,16S)-6,10-dihydroxy-5,7,9,9-tetramethyl-14-[(E)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-13,17-dioxabicyclo[14.1.0]heptadecane-8,12-dione
(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetyloxy)-1,9-dihydroxy-15-{[(2R,3S)-2-hydroxy-3-phenyl-3-(phenylformamido)propanoyl]oxy}-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl ben­zoate
(2aR-(2aα,4β,4aβ,6β,9α(α R,βS),11α,12α,12bα))-β-(Benzoylamino)-α-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester
(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl (aR,bS)-b-(benzoylamino)-a-hydroxybenzenepropanoate
(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-9-(((2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl)oxy)-12-(benzoyloxy)-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-1H-7,11-methanocyclodeca[3,4]benzo[1,2-b]oxete-6,12b-diyl diac­etate
4α,10β-bis(acetyloxy)-13α-[(2S,3S)-3-(benzoylamino)-2-hydroxy-3-phenylpropanoyloxy]-1,7β-dihydroxy-9-oxo-5β,20-epoxytax-11-en-2α-yl ben­zoate
5β,20-Epoxy-1,2-α,4,7β,10β,13α-hexahydroxytax-11-en-9-one 4,10-diacetate 2-ben­­zoate 13-ester with (2R,3S)-N-ben­zoyl-3-phenylisoser­ine
ACon1_​002231
Ben­zene­propanoic acid, β-(benzoylamino)- α-hydroxy-, 6,12b-bis(acetyl oxy)-12-(benzoyloxy)- 2a,3,4,4a,5,6,9,10,11,12,12a,12b,- dodecahydro-4,11- dihydroxy-4a,8,13,13-tetramethyl-5-oxo- 7,11-methano- 1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, [2aR- [2aα,4β,4aβ,6β,9α(α. R,βS),11α,12α,12aα,12bα]]-
BMS-181339-01
BPBio1_​000320
BSPBio_​000290
cMAP_​000068
DA8340700
DHP-107
DHP-208
Genax­ol
Gene­taxyl
Genex­ol
Genex­ol-PM
Intax­el
MEGxp0_​001940
MFCD00869953 [MDL num­ber]
Mito­tax
Nan­o­tax­el
OAS-PAC-100
Onco­Gel
Onx­ol ; Pax­ceed
Pacli­cal
Pacligel
Pax­ceed (Trade name)
Pax­ene (Trade name)
Pax­o­ral
Prestwick3_​000155
STOCK­1N-71343
TA1
Tax-11-en-9-one, 5β,20-epoxy-1,2α,4,7β, 10β,13α- hexa­­hy­­droxy-, 4,10-diacetate 2- benzoate,13-ester with (2R,3S)-N-ben­zoyl-3-phenylisoser­ine
Tax-11-en-9-one, 5β,20-epoxy-1,2α,4,7β,10β,13α- hexa­­hy­­droxy-, 4,10-diacetate 2-ben­­zoate, 13-ester with (2R,3S)-N-ben­zoyl-3-phenylisoser­ine (8CI)
Tax-11-en-9-one, 5β,20-epoxy-1,2α,4,7β,10β,13α-hexahydroxy-, 4,10-diacetate 2-ben­­zoate 13-ester with (2R,3S)-N-ben­zoyl-3-phenylisoser­ine (8CI)
Tax­ol®
Tax­ol ; Tax­ol A
Xorane

SMILES

CC1=C2C@HC)(C[C@@H]1OC(=O)C@@Hc6ccccc6)O)O)OC(=O)c7ccccc7)(CO4)OC(=O)C)O)C)OC(=O)C

Std­InChI

InChI=1S/C47H51NO14/c1-25-31(60-43(56)36(52)35(28-16-10-7-11-17-28)48-41(54)29-18-12-8-13-19-29)23-47(57)40(61-42(55)30-20-14-9-15-21-30)38-45(6,32(51)22-33-46(38,24-58-33)62-27(3)50)39(53)37(59-26(2)49)34(25)44(47,4)5/h7-21,31-33,35-38,40,51-52,57H,22-24H2,1-6H3,(H,48,54)/t31-,32-,33+,35-,36+,37+,38-,40-,45+,46-,47+/m0/s1

Std­InChIKey

RCINI­­CONZN­JX­QF-MZX­OD­­VAD­SA-N

Mol­e­c­u­lar Formula

C47H51NO14

Mol­e­c­u­lar Weight

853.92

Beil­stein Reg­istry Number

1420457

MDL Number

MFCD00869953

Prop­er­ties

Appear­ance

White to off-white powder

Safe­ty Data

Sym­bol

exclamation-mark-jpgexclamation-mark-jpgexclamation-mark-jpgGHS05, GHS07

Sig­nal Word

Dan­ger

Haz­ard statements

H315-H317-H318-H334-H335-H341-H361-H371

Pre­cau­tion­ary Statements

P260-P280-P305 + P351 + P338-P342P311

Per­son­al Pro­tec­tive Equipment

Eye­shields, Faceshields, full-face par­ti­cle res­pi­ra­tor type N100 (US), Gloves, res­pi­ra­tor car­tridge type N100 (US), type P1 (EN143) res­pi­ra­tor fil­ter, type P3 (EN 143) res­pi­ra­tor car­tridges and pur­pose. It may be tox­ic or haz­ardous, and should be han­dled only by qual­i­fied indi­vid­u­als trained in lab­o­ra­to­ry pro­ce­dures. The buy­er will be respon­si­ble to warn and inform any per­son that may be in con­tact with the prod­uct of the poten­tial risks and haz­ards, as well as to ensure that pur­chase, use and dis­pos­al of the prod­uct com­ply with local laws and regulations. 

RIDADR 

UN 3224A1 4.1 / PGII 

WGK Germany

3

RTECS

DA8340700

Spec­i­fi­ca­tions and Oth­er Infor­ma­tion of Our 10-DAB semi­syn­thet­ic pacli­tax­el CAS 33069-62-4

Iden­ti­fi­ca­tion Methods

HPLC

Puri­ty

99%~101%

Relat­ed substance

1.2%max

IO-Deacetyl-bac­­catin III

0.10%max

Bac­catin III 

0.2%max

Pho­todegradant

0.1%max

10-Deac­ctyl paclitaxel

0.2%max

2-Deben­­zoyl­­pa­­cli­­tax­­cl-2-pen­tenoate

0.7%max

Oxe­la­nen­ng opened,acetyl and ben­zoyl migrated

0.4%max

10-Ace­­toacetyl­­pa­­cli­­tax­el

0.4%max

10-Deacetyl-7-epi pacli­tax­el

0.4%max

7-Epipaclitaxel(E)

0.4%max

10,13-Bissidechain pacli­tax­el

0.4%max

7-Acetyl­­pa­­cli­­tax­el

0.5%max

13-Tes-bac­­catin III

0.1%max

7-Tes-pacli­­tax­el

0.2%max

Oth­ers

0.1%max of each

Resid­ual Solvents

Total

1490 ug/​g max

Dichloromethane

60 ug/​g max

n-Butanol

100 ug/​g max

Ace­tone

1000 ug/​g max

Petro­le­um ether

100 ug/​g max

Mois­ture

3.0%max

Heavy Met­als

0.002% max

Bac­te­r­i­al Endotoxins

Max 0.3EU/​mg Paclitaxel 

Total aer­o­bic microbial

Max 50cfu/​g Paclitaxel 

Staphau­reus, Pseudomonas aerug­i­nosa, Sal­mo­nel­la species and E.Coli

Meet the requirements

Residue on Ignition

0.2%max

Fun­gi

Max 10cfu/​g Paclitaxel 

Shelf Life

3 years

Stor­age

Under room tem­per­a­ture away from light

Pro­duc­tiv­i­ty

800kg/​year

Known Appli­ca­tion

It is an anti-tumor med­i­c­i­nal plants, for ovar­i­an can­cer, breast can­cer and the like.

This prod­uct is devel­oped by our R&D com­pa­ny Cam­ing Phar­ma­ceu­ti­cal Ltd(http://​www​.cam​ing​.com/), and here is the cor­re­spond­ing linkhttp://​www​.cam​ing​.com/​1​0​-​d​a​b​-​s​e​m​i​s​y​n​t​h​e​t​i​c​-​p​a​c​l​i​t​a​x​e​l​-​c​a​s​-​3​3​0​6​9​-​6​2​-4/

Quick Inquiry

Fill out our inquiry form and one of our experts will be in touch with you short­ly (Please change screen to hor­i­zon­tal for com­plete brows­ing if you are check­ing Wat­son on your mobile phone). 

























    Please prove you are human by select­ing the car.